Queen Mary Utilization of Antihypertensive Drugs Study: Side-effects of antihypertensive drugs

被引:14
作者
Cheung, BMY
Wong, YL
Lau, CP
机构
[1] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Sch Profess & Continuing Educ, Hong Kong, Hong Kong, Peoples R China
[3] Univ Sunderland, Sunderland SR2 7EE, Durham, England
关键词
angiotensin-converting enzyme inhibitor; beta-blocker; calcium channel blocker; drug utilization; hypertension; thiazide diuretic;
D O I
10.1111/j.1365-2710.2005.00662.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and objective: Effective prevention of cardiovascular events in hypertensive patients requires good control of blood pressure. Side-effects of antihypertensive drugs affect tolerability and compliance. Accordingly, we surveyed side-effects in the hypertension outpatient clinic. Methods: A total of 228 patients (109 men, 119 women) were interviewed in April-May 2004 in the Queen Mary Utilization of Antihypertensive Drugs Study. Results: The percentage of patients receiving no drug (life-style modification), one, two, three and over three drugs were 3, 30, 40, 22 and 6% respectively. The proportion of patients taking calcium channel blockers, beta-blockers (BB), angiotensin-converting enzyme inhibitors, thiazide diuretics, alpha-blockers and angiotensin receptor blockers were 65, 64, 33, 24, 4 and 7% respectively. Blood pressure on treatment was 144 +/- 21/82 +/- 11 mmHg. Among patients on antihypertensive drug therapy, 34% reported adverse effects: dizziness (9%), ankle swelling (7%), headache (5%), fatigue (4%), chest discomfort (3%) and cough (3%). Fewer patients on BBs reported side-effects (OR 0.46, P = 0.008). The likelihood of experiencing side-effects was unrelated to sex, age, weight, BMI, years of treatment, number of drugs used, heart rate on treatment or compliance. Conclusions: To achieve good blood pressure control, multiple drugs are used. Thiazides are underused whereas BBs are popular. The popularity of the latter may be related to its tolerability.
引用
收藏
页码:391 / 399
页数:9
相关论文
共 36 条
[1]   2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension [J].
Afridi, I ;
Canny, J ;
Yao, CH ;
Christensen, B ;
Cooper, RS ;
Kadiri, S ;
Hill, S ;
Kaplan, N ;
Kuschnir, E ;
Lexchin, J ;
Mendis, S ;
Poulter, N ;
Psaty, BM ;
Rahn, KH ;
Sheps, SG ;
Whitworth, J ;
Yach, D ;
Bengoa, R ;
Ramsay, L ;
Kaplan, N ;
Mendis, S ;
Poulter, N ;
Whitworth, J .
JOURNAL OF HYPERTENSION, 2003, 21 (11) :1983-1992
[2]  
*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
[3]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[4]   Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [J].
Brown, MJ ;
Palmer, CR ;
Castaigne, A ;
de Leeuw, PW ;
Mancia, G ;
Rosenthal, T ;
Ruilope, LM .
LANCET, 2000, 356 (9227) :366-372
[5]   Atenolol in hypertension: is it a wise choice? [J].
Carlberg, B ;
Samuelsson, O ;
Lindholm, LJ .
LANCET, 2004, 364 (9446) :1684-1689
[6]  
Cheung B. M. Y., 2003, Hong Kong Medical Journal, V9, P224
[7]  
Cheung Bernard M. Y., 2002, American Journal of Hypertension, V15, p210A, DOI 10.1016/S0895-7061(02)02840-6
[8]  
Cheung Bernard M. Y., 2002, American Journal of Hypertension, V15, p209A, DOI 10.1016/S0895-7061(02)02837-6
[9]   Amlodipine, felodipine, and isradipine in the treatment of Chinese patients with mild-to-moderate hypertension [J].
Cheung, BMY ;
Lau, CP ;
Wu, BZ .
CLINICAL THERAPEUTICS, 1998, 20 (06) :1159-1169
[10]  
CHEUNG BMY, 1999, J CLIN PHARMACOL, V39, pA969